Z Pharmaceuticals, a CNS-focused therapeutic development specialist, today announced the publication of a groundbreaking study in The ...

High blood pressure is a major health concern, affecting about 10% of adults worldwide. Many people with this condition rely ...

an L-type calcium channel blocker (LTCC), as a foundation for a novel therapy for ADHD. The findings provide robust validation of 3Z's cutting-edge high-throughput drug discovery platform and ...

The drugs most frequently used by these patients were diuretics, converting enzyme inhibitors, calcium channel blockers (CCB), lipid-lowering agents, and salicylates. Eczema was significantly ...

Clinical Relevance in Human Populations: Polygenic risk score analysis using the UK Biobank demonstrated that individuals with a high ADHD genetic burden who were prescribed amlodipine exhibited ...